The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers—Preclinical In Vivo Evaluation in Xenograft Tumor Models

Resistance formation of tumors against chemotherapeutics is the major obstacle in clinical cancer therapy. Although low molecular weight heparin (LMWH) is an important component in oncology referring to guideline-based antithrombotic prophylaxis of tumor patients, a potential interference of LMWH wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller, Thomas, Pfankuchen, Daniel Bastian, Wantoch von Rekowski, Kathleen, Schlesinger, Martin, Reipsch, Franziska, Bendas, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154624/
https://www.ncbi.nlm.nih.gov/pubmed/28467373
http://dx.doi.org/10.3390/molecules22050728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154624/
https://www.ncbi.nlm.nih.gov/pubmed/28467373
http://dx.doi.org/10.3390/molecules22050728

Ejemplares similares